Kids Home > Menactra Uses
Menactra offers protection against invasive meningococcal diseases, such as bacterial meningitis. The vaccine is recommended for certain groups of people, such as children between 11 and 18 years of age, people with a damaged spleen, and college freshman who live in dormitories. Off-label uses of Menactra include giving the vaccine to people under the age of 9 months or over the age of 55.
What Is Menactra Used For?Menactra® (meningococcal vaccine) is approved to provide protection against invasive meningococcal disease. It is used only to prevent meningococcal disease caused by Neisseria meningitidis; it does not provide protection against any other types of bacteria.
- Bacterial meningitis (a bacterial infection of the fluid surrounding the brain and spinal cord)
- Bloodstream infections.
- Almost all children and adolescents between 11 and 18 years of age
- College freshmen living in dormitories
- Laboratory workers who are routinely exposed to N. meningitidis
- United States military recruits
- Anyone living in or traveling to areas of the world where meningococcal disease is common
- Anyone with a damaged or removed spleen
- People with a specific immune system disorder known as "terminal complement component deficiency"
- People who might have been exposed to meningitis during an outbreak.